Last update Dec. 12, 2022
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Mebeverine Hydrochloride in other languages or writings:
Mebeverine Hydrochloride belongs to this group or family:
Main tradenames from several countries containing Mebeverine Hydrochloride in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 466 | daltons |
Protein Binding | 75 | % |
Tmax | 1 - 3 | hours |
T½ | 1. 1 - 2.5 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Antispasmodic drug with direct effect on intestinal smooth muscle and little anticholinergic effects. Used for treatment of Irritable Bowel Syndrome. Oral administration three times a day.
At latest update no published data on excretion into breast milk were found.
Although antimuscarinics can decrease prolactin production (Müller 1983, Masala 1982), once lactation is established, milk production depends more on the repeated stimulation of suckling than on prolactin levels.
During breastfeeding it may be prudent to avoid it or take a minimum dose over short periods of time, monitoring the production of milk, especially in the first weeks postpartum.